Paper41226322
Trans-Omic Analysis Identifies the 'PRMT1-STAT3-Integrin αVβ6 Axis' as a Novel Therapeutic Target in Tacrolimus-Induced Chronic Nephrotoxicity.
Nishida S and 4 others. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Trans-Omic Analysis Identifies the 'PRMT1-STAT3-Integrin αVβ6 Axis' as a Novel Therapeutic Target in Tacrolimus-Induced Chronic Nephrotoxicity. Papers, record 41226322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41226322
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Trans-Omic Analysis Identifies the 'PRMT1-STAT3-Integrin αVβ6 Axis' as a Novel Therapeutic Target in Tacrolimus-Induced Chronic Nephrotoxicity.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein-Arginine N-Methyltransferases | Major topic |
| STAT3 Transcription Factor | Major topic |
| Tacrolimus | Major topic |
| Integrins | Major topic |
| Kidney Diseases | Major topic |
| Animals | |
| Mice | |
| Male | |
| Proteomics | |
| Kidney | |
| Mice, Inbred ICR | |
| Kidney Transplantation | |
| Signal Transduction |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 3-2418-009 | Japan Research Foundation for Clinical Pharmacology | PubMed | ||
| 24K02579 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40634610 | The role of metabolism in shaping enzyme structures over 400 million years. | Nature | 2025 | https://conductscience.org/library/papers/40634610 | PubMed |
| 2 | 31357472 | Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31357472 | PubMed |
| 3 | 29277665 | Tacrolimus: An updated review on delivering strategies for multifarious diseases. | Eur J Pharm Sci | 2018 | https://conductscience.org/library/papers/29277665 | PubMed |
| 4 | 18294345 | Banff 07 classification of renal allograft pathology: updates and future directions. | Am J Transplant | 2008 | https://conductscience.org/library/papers/18294345 | PubMed |
| 5 | 39775984 | PRMT1-mediated BRD4 arginine methylation and phosphorylation promote partial epithelial-mesenchymal transformation and renal fibrosis. | FASEB J | 2025 | https://conductscience.org/library/papers/39775984 | PubMed |
| 6 | 19515016 | Rescue of anaemia and autoimmune responses in SOD1-deficient mice by transgenic expression of human SOD1 in erythrocytes. | Biochem J | 2009 | https://conductscience.org/library/papers/19515016 | PubMed |
| 7 | 7680544 | The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. | Am J Surg Pathol | 1993 | https://conductscience.org/library/papers/7680544 | PubMed |
| 8 | 18094377 | Reduced exposure to calcineurin inhibitors in renal transplantation. | N Engl J Med | 2007 | https://conductscience.org/library/papers/18094377 | PubMed |
| 9 | 32550552 | The ITGB6 gene: its role in experimental and clinical biology. | Gene X | 2020 | https://conductscience.org/library/papers/32550552 | PubMed |
| 10 | 30769897 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases. | Metabolites | 2019 | https://conductscience.org/library/papers/30769897 | PubMed |
| 11 | 28272322 | Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA). | Toxins (Basel) | 2017 | https://conductscience.org/library/papers/28272322 | PubMed |
| 12 | 29900117 | Multi-omics "upstream analysis" of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer. | EuPA Open Proteom | 2016 | https://conductscience.org/library/papers/29900117 | PubMed |
| 13 | 31422467 | Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model. | Metabolomics | 2019 | https://conductscience.org/library/papers/31422467 | PubMed |
| 14 | 39643697 | Integrins in the kidney - beyond the matrix. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/39643697 | PubMed |
| 15 | 16573777 | Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. | Am J Gastroenterol | 2006 | https://conductscience.org/library/papers/16573777 | PubMed |
| 16 | 16845066 | Composite Module Analyst: identification of transcription factor binding site combinations using genetic algorithm. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16845066 | PubMed |
| 17 | 29362864 | Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. | Arch Toxicol | 2018 | https://conductscience.org/library/papers/29362864 | PubMed |
| 18 | 39243926 | A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast (PLN-74809) ameliorates organ injury and fibrogenesis in fibrotic kidney disease. | Eur J Pharmacol | 2024 | https://conductscience.org/library/papers/39243926 | PubMed |
| 19 | 32147003 | The Many Faces of Calcineurin Inhibitor Toxicity-What the FK? | Adv Chronic Kidney Dis | 2020 | https://conductscience.org/library/papers/32147003 | PubMed |
| 20 | 19073714 | Building a knowledge base for systems pathology. | Brief Bioinform | 2008 | https://conductscience.org/library/papers/19073714 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589681 | Proteomic Characterization of Replication Stress and Impaired Antioxidant Defense in Tacrolimus-Induced Chronic Nephrotoxicity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589681 | PubMed |
| 41977381 | A Pathogenic ROCK-Signaling Network Involving a Lysine Deletion in Myh11 Renders Carriers Susceptible to Aortic Dissection. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977381 | PubMed |
| 41683712 | Artificial Intelligence in Nephrology-State of the Art on Theoretical Background, Molecular Applications, and Clinical Interpretation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683712 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41226322
GET https://conductscience.org/api/papers/v1/41226322/references?page=2